Cargando…

Prognostic significance of K-ras mutations in pancreatic cancer: a meta-analysis

BACKGROUND: K-ras gene mutations are common in patients with pancreatic cancer (PC); however, their prognostic value for PC remains inconclusive. This meta-analysis was performed to quantitatively evaluate the association between K-ras mutations and survival in patients with pancreatic cancer. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Lian-yuan, Zhang, Ling-fu, Xiu, Dian-rong, Yuan, Chun-hui, Ma, Zhao-lai, Jiang, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868030/ https://www.ncbi.nlm.nih.gov/pubmed/27183870 http://dx.doi.org/10.1186/s12957-016-0888-3

Ejemplares similares

Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients
por: Vincenzi, Bruno, et al.
Publicado: (2015)

Extrapancreatic Neuropathy Correlates with Early Liver Metastasis in Pancreatic Head Adenocarcinoma
por: Lu, Meng, et al.
Publicado: (2019)

Sensitization of Human Pancreatic Cancer Cells Harboring Mutated K-ras to Apoptosis
por: Shen, Ling, et al.
Publicado: (2012)

Establishment of a Macrophage Phenotypic Switch Related Prognostic Signature in Patients With Pancreatic Cancer
por: Li, Mu-xing, et al.
Publicado: (2021)

Identification of K‐ras Oncogene Mutations in the Pure Pancreatic Juice of Patients with Ductal Pancreatic Cancers
por: Watanabe, Hiroyuki, et al.
Publicado: (1993)

Multiple K‐ras Mutations in Hyperplasia and Carcinoma in Cases of Human Pancreatic Carcinoma
por: Matsubayashi, Hiroyuki, et al.
Publicado: (1999)

The Significance of Ras Activity in Pancreatic Cancer Initiation
por: Logsdon, Craig D., et al.
Publicado: (2016)

Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article
por: Li, Gang, et al.
Publicado: (2019)

Can K-ras Gene Mutation Be Utilized as Prognostic Biomarker for Colorectal Cancer Patients Receiving Chemotherapy? A Meta-Analysis and Systematic Review
por: Rui, Yuan-Yi, et al.
Publicado: (2013)

Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas
por: Campos, Manuel António, et al.
Publicado: (2020)

K-ras Mutational Status in Cytohistological Tissue as a Molecular Marker for the Diagnosis of Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Yang, Jing, et al.
Publicado: (2014)

Beyond the Genomic Mutation: Rethinking the Molecular Biomarkers of K-RAS Dependency in Pancreatic Cancers
por: Mottini, Carla, et al.
Publicado: (2020)

Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation
por: Ferguson, Robert, et al.
Publicado: (2023)

K-Ras Mutations in Non-Small-Cell Lung Cancer: Prognostic and Predictive Value
por: D'Arcangelo, Manolo, et al.
Publicado: (2012)

Dissected peripancreatic tissue margin is a critical prognostic factor and is associated with a K-ras gene mutation in pancreatic ductal adenocarcinoma
por: Nishizawa, Nobuyuki, et al.
Publicado: (2019)

Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis
por: Fu, Wen, et al.
Publicado: (2020)

The prognostic value of B7-H4 in pancreatic cancer: Systematic review and meta-analysis
por: Chen, Xin, et al.
Publicado: (2018)

Synergistic effects of sorafenib in combination with gemcitabine or pemetrexed in lung cancer cell lines with K-ras mutations
por: Li, Jing, et al.
Publicado: (2016)

K-Ras4A Plays a More Significant Role than K-Ras4B in Ductal Carcinoma of Breast
por: Mortazavipour, Mohamad Mahdi, et al.
Publicado: (2023)

Noninvasive Image Texture Analysis Differentiates K-ras Mutation from Pan-Wildtype NSCLC and Is Prognostic
por: Weiss, Glen J., et al.
Publicado: (2014)

Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer
por: Wang, Oliver H., et al.
Publicado: (2016)

K-Ras Peptide Mimotope Induces Antigen Specific Th1 and B-Cell Immune Responses against G12A-Mutated K-Ras Antigen in Balb/c Mice
por: Siak, Pui Yan, et al.
Publicado: (2021)

PLA2G2A Phospholipase Promotes Fatty Acid Synthesis and Energy Metabolism in Pancreatic Cancer Cells with K-ras Mutation
por: Zhang, Mingquan, et al.
Publicado: (2022)

Apoptosis of Human Pancreatic Carcinoma PC-2 Cells by an Antisense Oligonucleotide Specific to Point Mutated K-ras
por: Yongxiang, Wang, et al.
Publicado: (2013)

Immunization with nanovaccines containing mutated K-Ras peptides and imiquimod aggravates heterotopic pancreatic cancer induced in mice
por: Martínez-Pérez, Amparo, et al.
Publicado: (2023)

Prognostic significance of ras/p21 alterations in human ovarian cancer.
por: Scambia, G., et al.
Publicado: (1997)

The Relevance of Common K-RAS Gene Mutations and K-RAS mRNA Expression with Clinicopathological Findings and Survival in Breast Cancer
por: Kamian, Shaghayegh, et al.
Publicado: (2023)

Coexistence of K-ras mutations and HPV infection in colon cancer
por: Buyru, Nur, et al.
Publicado: (2006)

Mutations of K-ras oncogene in human adrenal tumours in Taiwan.
por: Lin, S. R., et al.
Publicado: (1998)

Fast simultaneous detection of K-RAS mutations in colorectal cancer
por: Chang, Ya-Sian, et al.
Publicado: (2009)

Spectrum of K ras mutations in Pakistani colorectal cancer patients
por: Murtaza, B.N., et al.
Publicado: (2013)

Comparison of K-ras mutations in lung, colorectal and gastric cancer
por: PENG, NANQIU, et al.
Publicado: (2014)

The prognostic impact of K-RAS mutations in adult acute myeloid leukemia patients treated with high-dose cytarabine
por: Ahmad, Ebtesam I, et al.
Publicado: (2011)

Frequent functional activation of RAS signalling not explained by RAS/RAF mutations in relapsed/refractory multiple myeloma
por: Wong, Kwan Yeung, et al.
Publicado: (2018)

Development of a novel multi-functional integrated bioconjugate effectively targeting K-Ras mutant pancreatic cancer
por: Wang, Yang-Yang, et al.
Publicado: (2022)

RAS Mutations and Oncogenesis: Not all RAS Mutations are Created Equally
por: Miller, Mark Steven, et al.
Publicado: (2012)

Killer K-Ras
por: Powell, Kendall
Publicado: (2006)

K-RAS Is…Complicated
por: Clark, Geoffrey J.
Publicado: (2023)

Mutations in the α4-α5 allosteric lobe of RAS do not significantly impair RAS signaling or self-association
por: Whaby, Michael, et al.
Publicado: (2022)

K-RAS Mutant Pancreatic Tumors Show Higher Sensitivity to MEK than to PI3K Inhibition In Vivo
por: Hofmann, Irmgard, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mjvtl8nhr5k43s8b5dte1roa74